Literature DB >> 30190113

Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism.

Céline Goyard1, Benoit Côté2, Vincent Looten3, Anne Roche1, Jean Pastré1, Jonathan Marey1, Benjamin Planquette4, Guy Meyer5, Olivier Sanchez6.   

Abstract

Signs and symptoms of pulmonary embolism (PE) are not specific and this can lead to a diagnostic delay. Little is known about the determinants of this delay and its prognostic implication. We conducted a retrospective analysis of a prospective cohort involving 514 patients with a first episode of PE. The diagnostic delay was defined as a time from first symptom onset to diagnosis of >3 days, corresponding of the median time in the population. Multivariable logistic regression analysis was performed to identify determinants of diagnostic delay. Prognostic implication was measured as the occurrence of 30-day all-cause mortality, haemodynamic collapse or recurrent PE. A total of 240 (47%) among 514 patients had a time from first symptom to diagnosis > 3 days. Previous deep vein thrombosis (OR 0.55, 95% Confidence Interval (CI), 0.32-0.93), immobilization (OR 0.52, 95% CI, 0.28-0.96), surgery (OR 0.31, 95% CI, 0.16-0.62), chest pain (OR 0.58, 95% CI, 0.39-0.86), syncope (OR 0.48, 95% CI, 0.23-1.01), dyspnea (OR 2.48, 95% CI, 1.57-3.91) and hemoptysis (OR 3.57, 95% CI, 1.40-9.07) were associated with diagnostic delay. Twenty-two patients (4.3%, 95%CI, 2.8-6.5) experienced an outcome event within 30 days. Among them, 15 patients (6.2% 95%CI, 3.7-10.3) had a diagnostic delay and 7 (2.6%, 95% CI 1.1-5.4) did not (p = 0.039). In this cohort, diagnostic delay is associated with the absence of major risk factors for PE or clinical features such as chest pain or syncope and the presence of dyspnea or hemoptysis. Diagnostic delay is associated with a worse 30-day prognosis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis delay; Prognosis; Pulmonary embolism; Risk factors

Mesh:

Year:  2018        PMID: 30190113     DOI: 10.1016/j.thromres.2018.08.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Application of human factors to improve usability of clinical decision support for diagnostic decision-making: a scenario-based simulation study.

Authors:  Pascale Carayon; Peter Hoonakker; Ann Schoofs Hundt; Megan Salwei; Douglas Wiegmann; Roger L Brown; Peter Kleinschmidt; Clair Novak; Michael Pulia; Yudi Wang; Emily Wirkus; Brian Patterson
Journal:  BMJ Qual Saf       Date:  2019-11-27       Impact factor: 7.035

2.  Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes.

Authors:  Nichole E Brunton; Waldemar E Wysokinski; David O Hodge; Danielle T Vlazny; Damon E Houghton; Ana I Casanegra
Journal:  Res Pract Thromb Haemost       Date:  2021-04-07

3.  Variable predictors of acute pulmonary embolism recurrence with duration of follow-up.

Authors:  Yi-Lan Yang; Ping Yuan; Chuan-Yu Wang; Bigyan Pudasaini; Yuan Li; Yan-Zhe Yu; Qin-Hua Zhao; Lan Wang; Su-Gang Gong; Rong Jiang; Wen-Hui Wu; Jing He; Jian Guo; Ci-Jun Luo; Hong-Ling Qiu; Chang Chen; Jin-Ling Li; Jin-Ming Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

4.  Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients.

Authors:  Federica Melazzini; Margherita Reduzzi; Silvana Quaglini; Federica Fumoso; Marco Vincenzo Lenti; Antonio Di Sabatino
Journal:  Front Med (Lausanne)       Date:  2021-04-30

5.  A systematic review and meta-analysis of diagnostic delay in pulmonary embolism.

Authors:  R van Maanen; E M Trinks-Roerdink; F H Rutten; G J Geersing
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.